| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $99,000 | 1 | 1 |
Sells | $5,180,572 | 136 | 99 |
| CARDOZA GEORGE | Chief Financial Officer | 1 | $99,000 | 8 | $66,413 | $32,587 |
| Puylaert Kevin | Chief Sales Officer | 0 | $0 | 7 | $6,344 | $-6,344 |
| HIBBS KATHY L | director | 0 | $0 | 3 | $140,087 | $-140,087 |
| Van Well Daan | Chief Legal Officer | 0 | $0 | 10 | $166,472 | $-166,472 |
| Valente Manuela | Chief People Officer | 0 | $0 | 9 | $183,591 | $-183,591 |
| Muken Ross | President | 0 | $0 | 14 | $249,702 | $-249,702 |
| Verma Abhimanyu | Chief Technology Officer | 0 | $0 | 9 | $283,143 | $-283,143 |
| Menu Philippe | Chief Medical Officer | 0 | $0 | 23 | $538,926 | $-538,926 |
| Xu Zhenyu | Chief Scientific Officer | 0 | $0 | 25 | $814,100 | $-814,100 |
| Camblong Jurgi | Chief Executive Officer | 0 | $0 | 28 | $2.73M | $-2.73M |
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, …
Over the last 12 months, insiders at SOPHiA GENETICS S.A. have bought $99,000 and sold $5.18M worth of SOPHiA GENETICS S.A. stock.
On average, over the past 5 years, insiders at SOPHiA GENETICS S.A. have bought $99,000 and sold $5.18M worth of stock each year.
Highest buying activity among insiders over the last 12 months: CARDOZA GEORGE (Chief Financial Officer) — $99,000.
The last purchase of 20,000 shares for transaction amount of $99,000 was made by CARDOZA GEORGE (Chief Financial Officer) on 2026‑06‑05.
| 2026-10-13 | Sale | Xu Zhenyu | Chief Scientific Officer | 4,000 0.0048% | $7.18 | $28,727 | +2.82% | |
| 2026-10-12 | Sale | Camblong Jurgi | Executive Chairman | 8,500 0.0116% | $7.26 | $61,671 | -0.28% | |
| 2026-10-12 | Sale | Menu Philippe | Chief Medical Officer | 5,000 0.0068% | $7.26 | $36,303 | -0.28% | |
| 2026-10-05 | Sale | Camblong Jurgi | Executive Chairman | 40,172 0.0539% | $8.13 | $326,526 | -11.10% | |
| 2026-10-05 | Sale | Muken Ross | Chief Executive Officer | 9,838 0.0132% | $8.13 | $79,971 | -11.10% | |
| 2026-10-05 | Sale | Xu Zhenyu | Chief Scientific Officer | 7,394 0.0099% | $8.12 | $60,075 | -11.10% | |
| 2026-10-05 | Sale | Van Well Daan | Chief Legal Officer | 6,168 0.0083% | $8.12 | $50,100 | -11.10% | |
| 2026-10-05 | Sale | CARDOZA GEORGE | Chief Financial Officer | 1,592 0.0021% | $8.10 | $12,897 | -11.10% | |
| 2026-10-05 | Sale | Valente Manuela | Chief People Officer | 4,240 0.0057% | $8.13 | $34,487 | -11.10% | |
| 2026-10-05 | Sale | Menu Philippe | Chief Medical Officer | 7,394 0.0099% | $8.13 | $60,100 | -11.10% | |
| 2026-10-05 | Sale | Verma Abhimanyu | Chief Technology Officer | 5,284 0.0071% | $8.12 | $42,929 | -11.10% | |
| 2026-10-05 | Sale | Puylaert Kevin | Chief Sales Officer | 216 0.0003% | $8.04 | $1,737 | -11.10% | |
| 2026-09-21 | Sale | Muken Ross | Chief Executive Officer | 422 0.0005% | $8.33 | $3,515 | -10.07% | |
| 2026-09-21 | Sale | CARDOZA GEORGE | Chief Financial Officer | 774 0.0009% | $8.33 | $6,447 | -10.07% | |
| 2026-09-14 | Sale | Xu Zhenyu | Chief Scientific Officer | 4,000 0.0054% | $7.88 | $31,538 | -3.50% | |
| 2026-09-14 | Sale | Menu Philippe | Chief Medical Officer | 5,000 0.0068% | $7.88 | $39,417 | -3.50% | |
| 2026-09-11 | Sale | Van Well Daan | Chief Legal Officer | 6,168 0.0081% | $7.63 | $47,089 | -3.05% | |
| 2026-09-10 | Sale | Camblong Jurgi | Executive Chairman | 8,500 0.0116% | $7.66 | $65,120 | +1.77% | |
| 2026-09-08 | Sale | HIBBS KATHY L | director | 6,250 0.0082% | $8.13 | $50,818 | -8.43% | |
| 2026-08-27 | Sale | Xu Zhenyu | Chief Scientific Officer | 10,000 0.0135% | $8.91 | $89,096 | -11.77% |
| Increased Positions | 26 | +63.41% | 867,860 | +4.89% |
| Decreased Positions | 16 | -39.02% | 299,865 | -1.69% |
| New Positions | 10 | New | 706,252 | New |
| Sold Out Positions | 9 | Sold Out | 129,117 | Sold Out |
| Total Postitions | 51 | +24.39% | 18M | +3.2% |